Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation, also known as blood clotting, is a complex physiological process by which blood changes from a liquid to a gel, forming a blood clot. This process is essential for hemostasis—the cessation of bleeding following vascular injury—and involves the activation, adhesion, and aggregation of platelets along with the deposition and maturation of fibrin. Coagulation prevents excessive bleeding when vessels are damaged but can also lead to pathological conditions if dysregulated.
Varies depending on the drug; examples include inhibiting specific coagulation factors (e.g., thrombin, factor Xa), inhibiting platelet aggregation, or enhancing fibrinolysis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation.